-+ 0.00%
-+ 0.00%
-+ 0.00%

X4 Pharmaceuticals FY 2025 net loss widens 111.2% to USD 79.2 million as revenue rises 1,250% to USD 35.1 million

Reuters·03/17/2026 11:02:43

Please log in to view news